This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPEDAF0IH_M.jpg
Orbimed Advisors’s holding in Prelude Therapeutics Incorporat established a new holding of about 917 thousand shares with the purchase.
Orbimed Advisors established new holdings in Prelude Therapeutics Incorporat
4 years ago
No Comments
Related Posts
Explainer-Michael Barr faces long to-do list as the U.S. Fed’s next Wall Street cop
April 15, 2022
Sprouts Farmers Market lifts guidance after mixed q3 results
November 8, 2022
Belgian lawyer guilty in 'Catch Me if You Can' Swiss money-laundering case
December 9, 2019
Australia fines Musk’s X platform $386,000 over anti-child abuse gaps
October 15, 2023
Microvast plunges 23% after failing to get a $200M grant from U.S. government
May 23, 2023
Meme stock Bed Bath & Beyond’s rally rages on
August 16, 2022
About The Author
